The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 10, 2009
Filed:
Aug. 01, 2003
Kathleen Clarence-smith, Washington, DC (US);
Jean-marie Georges Contreras, Fegersheim, FR;
Laurence Nathalie Deyon, Illkirch, FR;
Camille Georges Wermuth, Strasbourg, FR;
Kathleen Clarence-Smith, Washington, DC (US);
Jean-Marie Georges Contreras, Fegersheim, FR;
Laurence Nathalie Deyon, Illkirch, FR;
Camille Georges Wermuth, Strasbourg, FR;
Prestwick Pharmaceuticals, Inc., Washington, DC (US);
Abstract
The use of R(+)-2-amino-3-hydroxypropanoic acid derivatives, nitrogen substituted by a (C-C)alkyl, (C-C)alkenyl, 3-oxo(C-C)alkyl, 3-oxo(C-C)alken-2-yl, phenyl(C-C)alkyl, phenyl(C-C)alkenyl, gem-diphenyl(C-C)alkyl, gem-diphenyl(C-C)alkenyl, (C-C)alcanoyl, optionally N-substituted alanyl, optionally N,N'-disubstituted lysinoyl, phenyl(C-C)alkylydene or gem-diphenyl(C-C)alkylidene group, and of the pharmaceutically acceptable salts thereof, for preparation of medicaments intended for the treatment of CNS diseases due to reduced glycinergic transmission, particularly for the treatment of autism, schizophrenia and Alzheimer's disease, is described.